SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-24-010257
Filing Date
2024-07-19
Accepted
2024-07-19 07:10:34
Documents
15
Period of Report
2024-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp214678_8k.htm   iXBRL 8-K 36941
2 EXHIBIT 99.1 dp214678_ex9901.htm EX-99.1 13769
3 GRAPHIC image_001.jpg GRAPHIC 2465
  Complete submission text file 0000950103-24-010257.txt   236172

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bhc-20240715.xsd EX-101.SCH 3024
5 XBRL LABEL FILE bhc-20240715_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bhc-20240715_pre.xml EX-101.PRE 22366
17 EXTRACTED XBRL INSTANCE DOCUMENT dp214678_8k_htm.xml XML 3666
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 241126073
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)